+91 85238 33348
kumarpre@hotmail.comBreathlessness is often dismissed as a sign of ageing, reduced stamina, or general fatigue. But when breathlessness continues for months or years, especially in a person with risk factors such as hypertension or diabetes, it deserves a careful cardiac evaluation. In many patients, the symptom may not come from the lungs alone. It may be a signal that the heart valves are no longer working efficiently.
This case-based insight from Dr. R. K. Jain, Senior Consultant and Interventional Cardiologist, Director and Head of Cardiology at KIMS Hospital, Secunderabad, highlights the importance of advanced evaluation in a patient with complex aortic valve disease. The case involved severe aortic regurgitation with challenging native valve anatomy and was managed using a transcatheter aortic valve implantation approach with a dedicated Hanchor valve system.
The goal of sharing this case is not to make every patient compare themselves with one clinical situation. Every heart valve case is different. The purpose is to help patients and families understand why symptoms such as breathlessness should not be ignored, why imaging plays a major role in heart valve decisions, and how advanced structural heart procedures can offer selected patients a less invasive treatment pathway when planned by an experienced heart team.
|
Hero image to add on website Create a fresh, premium hero banner: Dr. R. K. Jain portrait + subtle aortic valve / catheter illustration + title overlay. Do not use raw cath-lab images as the hero because they are too clinical for first impression. |
Understanding the Problem: What Is Aortic Regurgitation?
The aortic valve sits between the left ventricle, the main pumping chamber of the heart, and the aorta, the large blood vessel that carries oxygen-rich blood to the body. In a healthy valve, blood moves forward from the heart into the aorta, and the valve closes firmly so that blood does not leak backward.
Aortic regurgitation occurs when the aortic valve does not close properly. Because of this leak, some blood flows back into the left ventricle after every heartbeat. Over time, the heart may have to work harder to maintain normal circulation. In the early stages, some patients may have only mild symptoms or no symptoms at all. As the leak becomes more significant, breathlessness, fatigue, reduced exercise tolerance, palpitations, chest discomfort, or swelling of the legs may appear.
In the uploaded case material, the patient had a history of breathlessness for a prolonged period. The clinical slide also notes hypertension and recently diagnosed diabetes, both of which can influence overall cardiovascular risk and treatment planning. Importantly, the source material describes preserved left ventricular function. This is clinically meaningful because valve disease is often best addressed before the heart muscle becomes permanently weakened.
For patients, the key message is simple: persistent breathlessness should not be accepted as normal without proper evaluation. A timely echocardiogram can reveal whether the heart valves are leaking or narrowed and whether the heart muscle is coping well.
Figure 1. Patient-friendly aortic regurgitation explainer. Best use: recreate this concept as a clean website illustration after design/permission review.
Why This Case Was More Complex Than a Routine Valve Procedure
Many people have heard of TAVI or TAVR in the context of aortic stenosis, where the aortic valve becomes narrowed and often heavily calcified. Calcification can sometimes help create a firm landing zone for a transcatheter valve. Aortic regurgitation can be more challenging, especially when the native valve is not heavily calcified and the aortic root or ascending aorta is dilated.
The case slides mention significant aortic regurgitation and complex native aortic valve anatomy. One deck also notes a dilated ascending aorta measuring 4.6 cm. These details matter because the interventional cardiologist must plan not only how to place the valve but also how to ensure that it stays stable, seals well, and functions properly after deployment.
In aortic regurgitation, the valve leaflets may be unable to close effectively, and the lack of calcification can make anchoring more demanding. The heart team must consider the annulus size, left ventricular outflow tract shape, sinus dimensions, access route, valve design, coronary access, and the possibility of paravalvular leakage or valve migration. This is why complex valve disease requires advanced imaging, careful case selection, device-specific planning, and experienced operators.
For a patient or family, the procedure may appear to be a single-day cath-lab intervention. Behind that procedure, however, there is a structured process of diagnosis, measurement, device selection, procedural planning, and post-procedure verification. That planning is what makes advanced TAVI/TAVR care precise and safe for appropriately selected patients.
Figure 2. Source clinical history slide. Best use: convert into a clean timeline infographic; avoid uploading this raw slide publicly.
The Role of Echocardiography and CT in Planning
A successful TAVI/TAVR procedure begins well before the valve is implanted. Echocardiography helps the team understand valve function, leakage, gradients, chamber size, and heart pumping strength. It gives dynamic information because the valve is seen while the heart is beating. In this case, pre-procedure echo images were used to understand the severity of valve dysfunction and guide decision-making.
CT analysis is equally important. CT provides a detailed anatomical map of the aortic annulus, LVOT, sinuses of Valsalva, aortic root, and access route. The Hanchor deck includes CT measurements such as annular perimeter, annular area, area-derived diameter, and LVOT diameter. These measurements help the heart team decide whether a transcatheter approach is suitable and which valve size and deployment strategy may be appropriate.
This planning phase is highly technical, but the patient benefit is practical. It reduces guesswork. It allows the cardiology team to understand the anatomy before entering the cath lab. It also supports procedural decisions such as the best viewing angle, the safest access route, and the most controlled positioning strategy.
For patients, scans may feel like routine tests. For the interventional cardiologist, these scans are the blueprint of the procedure. Every millimeter matters when a valve is being placed inside a moving heart.
Figure 3. Pre-procedure echocardiography analysis screenshot. Best use: crop and anonymize as an educational still or use as a 5-7 second echo loop if video is available.
Figure 4. CT planning screenshot showing annulus, LVOT, and aortic root measurements. Best use: highly recommended; crop cleanly and remove all identifiers.
Why a Dedicated Hanchor Valve System Was Used
The Hanchor valve presentation describes a dedicated balloon-expandable valve system designed for challenging aortic regurgitation anatomy. The slides highlight a short stent design and unique anchoring elements. The anchoring elements are intended to clamp the native leaflets and help the device remain stable in an anatomy where conventional anchoring may be less predictable.
The same presentation describes design goals such as curve adjustment, coaxial deployment, optimal positioning, reduced migration risk, controlled implantation depth, improved procedural controllability, and support for perivalvular sealing. It also notes that the design may facilitate post-procedural coronary access, which is important because many heart patients may need future coronary evaluation or treatment.
For patients, the important message is not the engineering language alone. The important message is that advanced valve therapy is not one-size-fits-all. Aortic valve disease can vary widely from one patient to another. A treatment plan must be tailored to the patient’s anatomy, symptoms, heart function, risk profile, and procedural suitability.
In this case, the dedicated Hanchor system was selected because the anatomy required a device strategy focused on secure anchoring and controlled positioning. This reflects the direction of modern structural heart care: precision planning, appropriate technology, and careful execution.
Figure 5. Hanchor valve design concepts. Best use: recreate as simplified valve-system illustration; check permissions before using manufacturer diagrams.
How the TAVI/TAVR Procedure Was Performed
The procedure was performed using a transfemoral approach, meaning the valve system was delivered through the femoral artery in the leg. This route is commonly used in TAVI/TAVR because it avoids opening the chest and allows the valve to be guided through the blood vessels to the heart.
The procedural slides show a sequence that includes aortic route angiography, crossing through the aortic arch, anchor deployment and positioning, final valve positioning, and deployment under imaging guidance. Fluoroscopy was used to visualize the catheters and valve system in real time. Echocardiography was used to assess valve function and confirm the post-procedure result.
One of the most important procedural goals in this type of case is stability. In aortic regurgitation with limited calcification, the valve must be positioned with great care. If the valve sits too high, too low, or without adequate anchoring, complications such as migration or leakage around the valve can occur. The Hanchor system’s anchoring concept was used to support more controlled deployment.
For a public-facing blog, it is better to use clean fluoroscopy stills and simplified labels rather than graphic surgical-access images. Patients need to understand the procedure without feeling overwhelmed. A short educational animation or an anonymized cath-lab montage can make this section very effective.
Figure 6. Aortic route angiogram and crossing through the aortic arch. Best use: 20-30 second anonymized fluoroscopy montage or 2 clean stills.
Figure 7. Anchor deployment and positioning across valve cusps. Best use: add to advanced case section with simple labels only.
Figure 8. Final positioning and deployment of Hanchor valve. Best use: use as still or short clip thumbnail for deployment step.
Post-Procedure Assessment and Clinical Outcome
A TAVI/TAVR procedure is not complete when the valve is deployed. The team must confirm that the valve is functioning well, that blood flow has improved, and that there is no significant leakage or procedural complication. This is where post-procedure echocardiography and hemodynamic assessment become important.
The uploaded Hanchor deck includes post-echocardiography analysis. The TAVR cath-lab deck includes final Doppler and pressure-screen images that support post-procedure assessment. The take-home slide states that there were no peri-procedural or post-procedural complications and that the patient was discharged in a clinically stable condition after TAVI.
For patients and families, this stage is reassuring because it confirms that the procedure achieved its immediate goal. For the cardiology team, it is a critical safety checkpoint. The patient continues to require follow-up, medications as advised, and periodic cardiac evaluation after discharge.
The broader clinical message is that advanced valve procedures are not just about technology. They are about accurate diagnosis, appropriate patient selection, precise execution, and structured follow-up.
Figure 9. Post-procedure echocardiography analysis. Best use: anonymized before/after echo visual with simple labels.
Figure 10. Take-home notes from the Hanchor deck. Best use: convert into a clean “Case outcome” card rather than uploading raw slide.
What Patients Should Learn From This Case
This case offers several important lessons for patients with breathlessness or known valve disease. First, symptoms should be evaluated early. Breathlessness, fatigue, and reduced activity tolerance can be early signs that the heart is under strain.
Second, an echocardiogram is a valuable first-line investigation when valve disease is suspected. It can detect leakage, narrowing, chamber enlargement, and changes in heart function.
Third, complex valve disease needs a specialized heart team. In cases involving severe aortic regurgitation, dilated aortic anatomy, or limited calcification, the decision is not simply whether to perform a procedure. The decision involves whether the anatomy is suitable, which device is appropriate, and how the procedure can be performed with maximum precision.
Fourth, TAVI/TAVR has become an important treatment option for selected patients, but it must be recommended only after detailed evaluation. Not every patient with valve disease is suitable for the same procedure. Some patients may need surgery, some may need medical optimization, and some may be candidates for transcatheter valve therapy.
Finally, follow-up care remains essential. Even after a successful valve procedure, patients should continue regular cardiac reviews, medication adherence, blood pressure control, diabetes management, and lifestyle measures recommended by their cardiologist.
When Patients Should Seek Evaluation for Valve Disease
Aortic valve disease is often silent in the beginning. Some patients continue their daily routine while the heart quietly works harder in the background. This is why symptoms must be interpreted carefully, especially when they are new, progressive, or limiting normal activity. Breathlessness while walking, climbing stairs, lying down, or doing work that was previously comfortable should not be ignored. Fatigue that does not improve with rest, chest heaviness, dizziness, palpitations, or swelling in the legs also deserve medical attention.
Patients who already have hypertension, diabetes, kidney disease, previous heart disease, or a known heart murmur should be even more cautious. These conditions do not mean that a valve procedure is always required, but they do mean that a structured cardiac evaluation is important. A clinical examination, ECG, echocardiogram, blood pressure review, and additional imaging when required can help clarify whether symptoms are due to valve disease, blocked arteries, rhythm problems, heart failure, lung disease, or another cause.
The most valuable part of early evaluation is that it gives patients options. When valve disease is detected before severe weakening of the heart muscle, the cardiology team can plan treatment more safely. Some patients may need monitoring and medicines. Some may require surgery. Some selected patients may be considered for a transcatheter option such as TAVI/TAVR after detailed imaging and heart-team discussion.
The decision should never be based on symptoms alone or on a single test in isolation. It should be based on the complete picture: the patient’s symptoms, valve severity, heart function, aortic anatomy, age, other medical conditions, procedural risk, and expected benefit. This is why expert review is essential in advanced valve disease.
Dr. R. K. Jain’s Approach to Advanced Structural Heart Care
With more than 25 years of cardiology experience and over 10,000 cardiac interventions, Dr. R. K. Jain brings a combination of clinical judgment, procedural expertise, and patient-focused communication to complex heart cases. As Director and Head of Cardiology at KIMS Hospital, Secunderabad, his work spans angioplasty, coronary stenting, pacemaker implantation, TAVI/TAVR, heart failure management, preventive cardiology, and complex cardiac procedures.
In cases such as this, experience matters because every decision has to be individualized. A technically advanced device is valuable only when it is used for the right patient, in the right anatomy, with the right imaging support and procedural planning.
For patients experiencing breathlessness, fatigue, chest discomfort, or reduced activity capacity, early consultation can make a significant difference. A simple evaluation may identify whether symptoms are related to valve disease, blocked arteries, rhythm problems, heart failure, or another condition.
If you or a loved one has been advised evaluation for aortic valve disease, severe aortic regurgitation, or TAVI/TAVR, consult Dr. R. K. Jain for a detailed cardiac assessment and treatment guidance.
Disclaimer
This article is for patient education and awareness. Treatment decisions depend on individual clinical evaluation, imaging findings, procedural risk, and medical suitability. Please consult a qualified cardiologist for personalized advice.
Patient-Friendly FAQs to Add Under the Blog
What symptoms can aortic valve disease cause?
Aortic valve disease may cause breathlessness, fatigue, reduced activity capacity, chest discomfort, palpitations, dizziness, or swelling. Some patients may have mild symptoms for a long time, so evaluation is important when symptoms persist.
Is TAVI/TAVR open-heart surgery?
TAVI/TAVR is a transcatheter procedure. In many cases, the new valve is delivered through a blood vessel in the leg rather than through open-heart surgery. Suitability depends on clinical condition and imaging findings.
Can TAVI/TAVR be used for aortic regurgitation?
TAVI/TAVR is more commonly known for aortic stenosis, but selected aortic regurgitation cases may be considered when anatomy, risk profile, and device suitability support a transcatheter approach. The decision must be individualized.
Why are CT and echocardiography needed before TAVI/TAVR?
Echocardiography shows valve function and heart pumping performance. CT gives precise measurements of the annulus, LVOT, aortic root, and access route. Together, these tests help the heart team plan the safest approach.
Who should evaluate a patient for advanced valve treatment?
Patients with severe valve disease should be evaluated by an experienced cardiologist or structural heart team. The decision may involve interventional cardiology, imaging experts, cardiac surgery, anesthesia, and critical care support depending on the case.